| RS730880260 |
NECTIN4
|
Health Risk |
Pathogenic |
Ectodermal dysplasia-syndactyly syndrome 1, Ectodermal dysplasia-syndactyly syndrome 1 |
| RS730880261 |
CUL7
|
Health Risk |
Pathogenic |
3M syndrome 1, CUL7-related disorder |
| RS730880262 |
CUL7
|
Health Risk |
Pathogenic |
3M syndrome 1, 3M syndrome 1 |
| RS730880263 |
CUL7
|
Health Risk |
Pathogenic |
3M syndrome 1, 3M syndrome 1 |
| RS730880264 |
ALDH3A2
|
Health Risk |
Pathogenic |
Sjögren-Larsson syndrome, Cerebral palsy |
| RS730880265 |
MCCC2
|
Health Risk |
Likely pathogenic |
3-methylcrotonyl-CoA carboxylase 2 deficiency, 3-methylcrotonyl-CoA carboxylase 2 deficiency |
| RS730880266 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS730880267 |
NAGS
|
Health Risk |
Pathogenic |
Hyperammonemia, type III |
| RS730880268 |
USH1G
|
Health Risk |
Pathogenic |
Usher syndrome type 1G, Usher syndrome type 1G |
| RS730880269 |
SECISBP2
|
Health Risk |
Pathogenic |
Thyroid hormone metabolism, abnormal 1 |
| RS730880270 |
SLC45A2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS730880271 |
SLC45A2
|
Health Risk |
Pathogenic |
Oculocutaneous albinism type 4, Oculocutaneous albinism type 4 |
| RS730880272 |
FBXO7
|
Health Risk |
Pathogenic |
Parkinsonian-pyramidal syndrome, Parkinsonian-pyramidal syndrome |
| RS730880273 |
MERTK
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 38, Retinal dystrophy |
| RS730880274 |
TBX19
|
Health Risk |
Pathogenic |
Congenital isolated adrenocorticotropic hormone deficiency, TBX19-related disorder |
| RS730880275 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS730880276 |
CNTNAP2
|
Health Risk |
Pathogenic |
Cortical dysplasia-focal epilepsy syndrome, Cortical dysplasia-focal epilepsy syndrome |
| RS730880277 |
FANCF
|
Health Risk |
Pathogenic |
Fanconi anemia complementation group F, Fanconi anemia |
| RS730880278 |
FANCF
|
Health Risk |
Conflicting classifications of pathogenicity |
Fanconi anemia complementation group F, Fanconi anemia |
| RS730880279 |
DDX11
|
Health Risk |
Pathogenic |
Warsaw breakage syndrome, Warsaw breakage syndrome |
| RS730880280 |
DDX11
|
Health Risk |
Pathogenic |
Warsaw breakage syndrome, Warsaw breakage syndrome |
| RS730880281 |
GHR
|
Health Risk |
Pathogenic |
Laron-type isolated somatotropin defect, Laron-type isolated somatotropin defect |
| RS730880282 |
GHR
|
Health Risk |
Pathogenic |
Laron syndrome with elevated serum GH-binding protein, Laron syndrome with elevated serum GH-binding protein |
| RS730880284 |
SELP
|
Health Risk |
Likely pathogenic |
Premature coronary artery atherosclerosis, Premature coronary artery atherosclerosis |
| RS730880285 |
COL7A1
|
Health Risk |
Pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS730880286 |
COL7A1
|
Health Risk |
Likely pathogenic |
Recessive dystrophic epidermolysis bullosa, Recessive dystrophic epidermolysis bullosa |
| RS730880287 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS730880288 |
BRCA1
|
Health Risk |
Pathogenic |
Breast-ovarian cancer, familial |
| RS730880289 |
DES
|
Health Risk |
Pathogenic |
Desmin-related myofibrillar myopathy, Desmin-related myofibrillar myopathy |
| RS730880290 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 28 |
| RS730880291 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 28 |
| RS730880292 |
WWOX
|
Health Risk |
Pathogenic |
Developmental and epileptic encephalopathy, 28 |
| RS730880293 |
LONP1
|
Health Risk |
Pathogenic |
CODAS syndrome, CODAS syndrome |
| RS730880294 |
TSEN2
|
Health Risk |
Pathogenic |
Pontocerebellar hypoplasia type 2B, Pontocerebellar hypoplasia type 2B |
| RS730880295 |
LACC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Juvenile arthritis due to defect in LACC1, Juvenile arthritis due to defect in LACC1 |
| RS730880296 |
CD3D
|
Health Risk |
Pathogenic/Likely pathogenic |
Immunodeficiency 19, CD3D-related disorder |
| RS730880297 |
ITGB6
|
Health Risk |
Pathogenic |
Amelogenesis imperfecta type 1H, Amelogenesis imperfecta type 1H |
| RS730880298 |
ITGB6
|
Health Risk |
Likely pathogenic |
Amelogenesis imperfecta type 1H, Amelogenesis imperfecta type 1H |
| RS730880299 |
DCDC2
|
Health Risk |
Pathogenic |
Nephronophthisis 19, Isolated neonatal sclerosing cholangitis |
| RS730880300 |
CRB2
|
Health Risk |
Conflicting classifications of pathogenicity |
Ventriculomegaly-cystic kidney disease, Ventriculomegaly-cystic kidney disease |
| RS730880301 |
CUL7
|
Health Risk |
Pathogenic |
Yakut short stature syndrome, Yakut short stature syndrome |
| RS730880302 |
PINK1
|
Health Risk |
Pathogenic |
Autosomal recessive early-onset Parkinson disease 6, Autosomal recessive early-onset Parkinson disease 6 |
| RS730880303 |
NAGS
|
Health Risk |
Likely pathogenic |
Hyperammonemia, type III |
| RS730880304 |
ALG2
|
Health Risk |
Pathogenic |
ALG2-congenital disorder of glycosylation, ALG2-congenital disorder of glycosylation |
| RS730880305 |
HSD17B3
|
Health Risk |
Pathogenic |
Testosterone 17-beta-dehydrogenase deficiency, Testosterone 17-beta-dehydrogenase deficiency |
| RS730880306 |
LPIN1
|
Health Risk |
Pathogenic |
Myoglobinuria, acute recurrent |
| RS730880307 |
PRKRA
|
Health Risk |
Pathogenic |
Dystonia 16, Dystonia 16 |
| RS730880308 |
GHR
|
Health Risk |
Pathogenic |
Short stature due to partial GHR deficiency, Short stature due to partial GHR deficiency |
| RS730880309 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS730880310 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS730880311 |
AUH
|
Health Risk |
Pathogenic |
3-methylglutaconic aciduria type 1, 3-methylglutaconic aciduria type 1 |
| RS730880312 |
AUH
|
Health Risk |
Pathogenic/Likely pathogenic |
3-methylglutaconic aciduria type 1, AUH-related disorder |
| RS730880313 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS730880314 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS730880315 |
RUNX2
|
Health Risk |
Pathogenic |
Cleidocranial dysostosis, Cleidocranial dysostosis |
| RS730880316 |
RPIA
|
Health Risk |
Pathogenic |
Deficiency of ribose-5-phosphate isomerase, Deficiency of ribose-5-phosphate isomerase |
| RS730880317 |
PDE6B
|
Health Risk |
Pathogenic |
Retinitis pigmentosa 40, Retinal dystrophy |
| RS730880318 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, ZAP70-related disorder |
| RS730880319 |
ZAP70
|
Health Risk |
Pathogenic |
Combined immunodeficiency due to ZAP70 deficiency, Combined immunodeficiency due to ZAP70 deficiency |
| RS730880320 |
CXCR4
|
Health Risk |
Pathogenic/Likely pathogenic |
Warts, hypogammaglobulinemia |
| RS730880321 |
MGP
|
Health Risk |
Pathogenic |
Keutel syndrome, Keutel syndrome |
| RS730880322 |
MGP
|
Health Risk |
Pathogenic |
Keutel syndrome, Keutel syndrome |
| RS730880323 |
MKS1
|
Health Risk |
Pathogenic |
Meckel syndrome, type 1 |
| RS730880324 |
BRAT1
|
Health Risk |
Pathogenic/Likely pathogenic |
Neonatal-onset encephalopathy with rigidity and seizures, Inborn genetic diseases |
| RS730880325 |
GUCY2C
|
Health Risk |
Pathogenic |
Meconium ileus, Meconium ileus |
| RS730880326 |
TCF12
|
Health Risk |
Pathogenic |
TCF12-related craniosynostosis, TCF12-related craniosynostosis |
| RS730880328 |
PTPN11
|
Health Risk |
Conflicting classifications of pathogenicity |
Metachondromatosis, Noonan syndrome 1 |
| RS730880329 |
RBCK1
|
Health Risk |
Pathogenic |
Polyglucosan body myopathy 1 without immunodeficiency, Polyglucosan body myopathy type 1 |
| RS730880330 |
RBCK1
|
Health Risk |
Pathogenic/Likely pathogenic |
Polyglucosan body myopathy type 1, Polyglucosan body myopathy 1 without immunodeficiency |
| RS730880331 |
NIPBL
|
Health Risk |
Pathogenic |
Cornelia de Lange syndrome 1, Cornelia de Lange syndrome 1 |
| RS730880335 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880336 |
MYBPC3
|
Health Risk |
Pathogenic |
Cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880337 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880338 |
GJB2
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 1A, Rare genetic deafness |
| RS730880341 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy 4, Hypertrophic cardiomyopathy |
| RS730880343 |
TTN
|
Health Risk |
Likely pathogenic |
Primary dilated cardiomyopathy, Primary dilated cardiomyopathy |
| RS730880344 |
LAMP2
|
Health Risk |
Likely pathogenic |
Danon disease, Hypertrophic cardiomyopathy |
| RS730880345 |
LDB3
|
Health Risk |
Pathogenic |
Myofibrillar myopathy 4, Cardiovascular phenotype |
| RS730880347 |
DSG2
|
Health Risk |
Conflicting classifications of pathogenicity |
Arrhythmogenic right ventricular dysplasia 10, Cardiovascular phenotype |
| RS730880349 |
USH2A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Usher syndrome type 2A |
| RS730880351 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS730880352 |
EMD
|
Health Risk |
Pathogenic |
Neuromuscular disease, X-linked Emery-Dreifuss muscular dystrophy |
| RS730880355 |
ELN
|
Health Risk |
Pathogenic |
Supravalvar aortic stenosis, Supravalvar aortic stenosis |
| RS730880356 |
FBN1
|
Health Risk |
Pathogenic |
Marfan syndrome, Marfan syndrome |
| RS730880357 |
PCDH15
|
Health Risk |
Conflicting classifications of pathogenicity |
Usher syndrome type 1F, Autosomal recessive nonsyndromic hearing loss 23 |
| RS730880359 |
TMC1
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS730880361 |
MYBPC3
|
Health Risk |
Pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880362 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Cardiomyopathy |
| RS730880365 |
TTN
|
Health Risk |
Pathogenic/Likely pathogenic |
Primary dilated cardiomyopathy, Cardiomyopathy |
| RS730880366 |
MYBPC3
|
Health Risk |
Pathogenic/Likely pathogenic |
Hypertrophic cardiomyopathy, Hypertrophic cardiomyopathy |
| RS730880367 |
MYO7A
|
Health Risk |
Pathogenic |
Rare genetic deafness, Usher syndrome type 1 |
| RS730880368 |
WFS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Wolfram syndrome 1, Inborn genetic diseases |
| RS730880369 |
ADGRV1
|
Health Risk |
Pathogenic |
Rare genetic deafness, Rare genetic deafness |
| RS730880370 |
ABCC9
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1O, Atrial fibrillation |
| RS730880371 |
TTN
|
Health Risk |
Conflicting classifications of pathogenicity |
Dilated cardiomyopathy 1G, Autosomal recessive limb-girdle muscular dystrophy type 2J |
| RS730880372 |
GAA
|
Health Risk |
Pathogenic |
Glycogen storage disease, type II |
| RS730880374 |
KCNH2
|
Health Risk |
Likely pathogenic |
Long QT syndrome 2, Long QT syndrome 2 |
| RS730880377 |
CRB2
|
Health Risk |
Pathogenic |
Ventriculomegaly-cystic kidney disease, Ventriculomegaly-cystic kidney disease |
| RS730880388 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hypertrophic cardiomyopathy 11, Dilated cardiomyopathy 1R |
| RS730880401 |
ACTC1
|
Health Risk |
Conflicting classifications of pathogenicity |
Cardiomyopathy, Cardiomyopathy |